Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway
Sclerostin is a product of mature osteocytes embedded in mineralised bone and is a negative regulator of bone mass and osteoblast differentiation. While evidence suggests that sclerostin has an anti-anabolic role, the possibility also exists that sclerostin has catabolic activity. To test this we tr...
Main Authors: | Wijenayaka, Asiri R., Kogawa, Masakazu, Lim, Hui Peng, Bonewald, Lynda F., Findlay, David M., Atkins, Gerald J. |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186800/ |
Similar Items
-
Mechanical loading response in trabecular bone is abrogated by sclerostin - A direct demonstration
by: Khalid, Kamarul Ariffin, et al.
Published: (2012) -
The Amazing Osteocyte
by: Bonewald, Lynda F
Published: (2011) -
Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone.
by: Jinhu Xiong, et al. -
Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone
by: Xiong, Jinhu, et al.
Published: (2015) -
Osteocyte Remodeling of the Perilacunar and Pericanalicular Matrix
by: Qing, Hai, et al.
Published: (2009)